Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt reflects on a year marked by promising clinical trial results and a landmark partnership with Merck. He highlights progress in developing treatments for autoimmune diseases and anticipates milestones for the year ahead.
Copyright 2024 – Finance News Network
Source: Finance News Network
30 Jul 2021 - Novatti Group Limited (ASX:NOV) CEO, Peter Cook, provides an update on activities from the company's June quarter, discussing growth in platforms and infrastructure and the recent capital raise.
Read More04 Nov 2022 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow discusses the company's new agreement with Case Western Reserve University.
Read More20 Nov 2023 - Dotz Nano (ASX:DTZ) navigates global challenges, focusing on carbon capture tech after strategic acquisitions and collaborations. CEO Sharon Malka discusses their resilient approach and plans for growth.
Read More29 Feb 2024 - Mitch Thomas - CFO - Latin Resources (ASX:LRS) is exploring and developing sustainable minerals in Australia and Latin America to provide the planet with environmentally friendly products.
Read More07 Sep 2023 - Empire Energy Group (ASX:EEG) CEO Alex Underwood discusses large scale future well drilling projects, and anticipates commercial production by 2025.
Read More25 Sep 2023 - Wally Graham of Resources Roadhouse at the New World Metals Conference, speaking with Dean Tuck, Managing Director of Dreadnought Resources (ASX:DRE).
Read More02 Feb 2021 - Centuria Industrial REIT (ASX:CIP) Fund Manager, Jesse Curtis talks 1H21 highlights, acquisitions, leasing activity and second half guidance.
Read More22 Jun 2023 - European Metals Holdings (ASX:EMH) Cinovec Project is strategically located in the heart of the growing European EV ecosystem in the northwest of the Czech Republic. Cinovec is a large historic lithium resource, with a clean pathway to underground development. EMH’s 51 per cent JV partner is the national utility CEZ a subsidiary of CEZ Group, which is owned 70 per cent by the Czech Government.
Read More30 Mar 2020 - XTEK Limited (ASX:XTE) Managing Director Philippe Odouard talks 1H20 results, the company's front-line products for the Australian Defence Force and police forces, US strategy and outlook.
Read More07 Jun 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's phase 1 trial results for its chlorotoxin CAR T (CLTX CAR T) cell therapy targeting glioblastoma.
Read More
